Pallas Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
+6,240
New +$546K 0.02% 520
2025
Q3
– Sell
-2,719
Closed -$247K – 893
2025
Q2
$247K Sell
2,719
-1,103
-29% -$101K 0.01% 708
2025
Q1
$358K Buy
3,822
+508
+15% +$45.5K 0.01% 555
2024
Q4
$301K Sell
3,314
-236
-7% -$22.5K 0.01% 469
2024
Q3
$354K Sell
3,550
-4,723
-57% -$481K 0.02% 437
2024
Q2
$815K Buy
8,273
+1,757
+27% +$162K 0.04% 230
2024
Q1
$587K Sell
6,516
-1,097
-14% -$92.9K 0.02% 261
2023
Q4
$607K Buy
+7,613
New +$572K 0.03% 246
2022
Q4
– Sell
-3,858
Closed -$279K – 274
2022
Q3
$279K Buy
+3,858
New +$303K 0.03% 209

Other funds holding CL

Pallas Capital Advisors's CL Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in Colgate-Palmolive (CL) in Q2 2026: 6,240 shares worth $572K. The stake represents 0.02% of the portfolio and ranks #520 among its holdings. This is a return to the name: Pallas Capital Advisors previously reported a position in CL as recently as Q2 2025.

Pallas Capital Advisors first reported a position in CL in Q3 2022 and has held it in 9 quarters since. The position peaked at $815K in Q2 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Pallas Capital Advisors held 6,240 shares of Colgate-Palmolive worth $572K as of Q2 2026.
  • Colgate-Palmolive was a new Pallas Capital Advisors position in Q2 2026.
  • Colgate-Palmolive made up 0.02% of Pallas Capital Advisors's portfolio in Q2 2026, its #520 holding.
  • Pallas Capital Advisors first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 9 quarters since.
  • Pallas Capital Advisors's Colgate-Palmolive position peaked at $815K in Q2 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.